Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nuclear and Mitochondrial Genome, Epigenome and Gut Microbiome: Emerging Molecular Biomarkers for Parkinson's Disease.

International journal of molecular sciences - 11 Sept 2021

Fonseca Cabral Gleyce, Schaan Ana Paula, Cavalcante Giovanna C, Sena-Dos-Santos Camille, de Souza Tatiane Piedade, Souza Port's Natacha M, Dos Santos Pinheiro Jhully Azevedo, Ribeiro-Dos-Santos Ândrea, Vidal Amanda F

Abstract excerpt

BACKGROUND: Parkinson's disease (PD) is currently the second most common neurodegenerative disorder, burdening about 10 million elderly individuals worldwide. The multifactorial nature of PD poses a difficult obstacle for understanding the mechanisms involved in its onset and progression. Currently, diagnosis depends on the appearance of clinical signs, some of which are shared among various neurologic disorders,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Epigenome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gastrointestinal Microbiome

Share to Genetic Variation

Share to Genome, Human

Share to Genome, Mitochondrial

Share to Parkinson Disease

Share to Parkinson's Disease Mechanisms and Treatments

Source

Open in PubMed Open full text

Identifiers

PMID: 34576000
DOI: 10.3390/ijms22189839
PMCID: PMC8471599

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nuclear and Mitochondrial Genome, Epigenome and Gut Microbiome: Emerging Molecular Biomarkers for Parkinson's Disease.PMID 34576000Read ↗

Gut microbiota, 1013 new pieces in the Parkinson's disease puzzleSemantic proximity Read ↗

The Impact of microRNAs on Mitochondrial Function and Immunity: Relevance to Parkinson’s DiseaseSemantic proximity Read ↗

From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular MechanismsSemantic proximity Read ↗

Parkinson's Disease, Parkinsonisms, and Mitochondria: the Role of Nuclear and Mitochondrial DNA.Semantic proximity Read ↗

Elucidating the dysbiotic features of gut microbiome, interaction with the human genome, and utility as a biomarker for treatment of Parkinson’s diseaseSemantic proximity Read ↗

Gut microenvironmental changes as a potential trigger in Parkinson’s disease through the gut–brain axisSemantic proximity Read ↗

Microbiome signature of Parkinson disease in healthy and genetically at-risk individualsSemantic proximity Read ↗

Microbiome signatures of virulence in the oral-gut-brain axis influence Parkinson’s disease and cognitive decline pathophysiologySemantic proximity Read ↗

Gut microbiome in Parkinson's disease: New insights from meta-analysisSemantic proximity Read ↗

Integrated multi-cohort analysis of the Parkinson’s disease gut metagenomeSemantic proximity Read ↗

Microbiome-based biomarkers to guide personalized microbiome-based therapies for Parkinson’s diseaseSemantic proximity Read ↗

Microbiome signatures of virulence in the oral-gut-brain axis influence Parkinson’s disease and cognitive decline pathophysiologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.